MSNBC
MSNBC 21 Apr 2020

Expert: 'I've Never Seen A More Rigorous Chase For Any Vaccine'

Description:

Jon Cohen, a staff writer for Science Magazine, tells Lawrence O'Donnell the race to develop a COVID-19 vaccine is "more rigorous" than any chase for a vaccine he has seen in his more than 30 years covering infectious diseases and vaccines. Cohen says he's hopeful because a COVID-19 vaccine does not seem "that tough of a scientific nut to crack." Aired on 4/21/2020.


CNN's Sara Sidner reports on the ongoing protest over the death of George Floyd in Minneapolis, despite the curfew order.

#Floyd
Former National Security Council member General Barry McCaffrey and former special presidential envoy for the Global Coalition to Defeat ISIS Brett McGurk on why they believe the national security process is broken amid reports the U.S. had intelligence that Russia offered and paid the Taliban bounty to kill U.S. troops. Aired on 6/30/2020.
Despite protests from the radical left and the mainstream media, statistics show America's police officers save more black lives than any other organization in the country. Countless Americans actually wouldn't be here today if it weren't for our police. One America's Pearson Sharp explains.
Another 1.48 million more Americans filed for unemployment benefits last week, bringing the total number of claims during the coronavirus pandemic to nearly 50 million. Aired on 6/25/2020.

… show captions ↓
MAGAZINE. HE HAS COVERED INFECTIOUS
HE HAS COVERED INFECTIOUS DISEASES AND VACCINES FOR OVER
DISEASES AND VACCINES FOR OVER 30 YEARS.
30 YEARS. JOHN, WHERE ARE WE IN THE CHASE
JOHN, WHERE ARE WE IN THE CHASE FOR THE VACCINE?
FOR THE VACCINE? >> I’VE NEVER SEEN A MORE
>> I’VE NEVER SEEN A MORE RIGOROUS CHASE FOR ANY VACCINE.
RIGOROUS CHASE FOR ANY VACCINE. THERE ARE OVER 70 EFFORTS UNDER
THERE ARE OVER 70 EFFORTS UNDER WAY RIGHT NOW.
WAY RIGHT NOW. FIVE HAVE ALREADY START THEEDED
FIVE HAVE ALREADY START THEEDED CLINICAL TRIALS.
CLINICAL TRIALS. THE CLOCK STARTS ON JANUARY 10th
THE CLOCK STARTS ON JANUARY 10th WHEN THE VIRUS IS FIRST PUBLICLY
WHEN THE VIRUS IS FIRST PUBLICLY DESCRIBED WITH THE SEQUENCE.
DESCRIBED WITH THE SEQUENCE. THAT’S A REMARKABLE PERIOD OF
THAT’S A REMARKABLE PERIOD OF TIME.
TIME. I MEAN FROM NOW TO THEN, I’VE
I MEAN FROM NOW TO THEN, I’VE NEVER SEEN ANYTHING LIKE THIS.
NEVER SEEN ANYTHING LIKE THIS. SO THERE’S A TREMENDOUS AMOUNT
SO THERE’S A TREMENDOUS AMOUNT OF ACTIVITY.
OF ACTIVITY. THERE’S A LOT OF INVESTMENT.
THERE’S A LOT OF INVESTMENT. THERE ARE A LOT OF VERY SMART
THERE ARE A LOT OF VERY SMART PEOPLE TRYING TO DO IT.
PEOPLE TRYING TO DO IT. BUT, YOU KNOW, THE QUESTION
BUT, YOU KNOW, THE QUESTION YOU’RE RAISING IS WHEN ARE WE
YOU’RE RAISING IS WHEN ARE WE GOING TO BE ABLE TO GO TO A
GOING TO BE ABLE TO GO TO A MOVIE THEATER WITH THE VACCINE
MOVIE THEATER WITH THE VACCINE IN OUR BODIES AND FEEL GREAT?
IN OUR BODIES AND FEEL GREAT? I DON’T KNOW.
I DON’T KNOW. NOBODY KNOWS.
NOBODY KNOWS. AND ANYONE WHO TELLS YOU THEY DO
AND ANYONE WHO TELLS YOU THEY DO KNOW ISN’T TELLING YOU THE
KNOW ISN’T TELLING YOU THE TRUTH.
TRUTH. >> AND IN THE COMPETITION, IS
>> AND IN THE COMPETITION, IS THIS IS A COMPETITION, OR IS
THIS IS A COMPETITION, OR IS THIS KIND OF A COOPERATIVE
THIS KIND OF A COOPERATIVE EFFORT AMONG DIFFERENT
EFFORT AMONG DIFFERENT RESEARCHERS ON GETTING TO A
RESEARCHERS ON GETTING TO A VACCINE?
VACCINE? >> I -- I THINK THERE’S A
>> I -- I THINK THERE’S A REMARKABLE ATTEMPT TO COORDINATE
REMARKABLE ATTEMPT TO COORDINATE THIS AND TO COLLABORATE.
THIS AND TO COLLABORATE. SCIENTISTS DON’T ALWAYS GET
SCIENTISTS DON’T ALWAYS GET ALONG AND DON’T ALWAYS
ALONG AND DON’T ALWAYS COLLABORATE.
COLLABORATE. THERE ALWAYS IS COMPETITION.
THERE ALWAYS IS COMPETITION. SOME OF IT’S HEALTHY.
SOME OF IT’S HEALTHY. SOME OF IT ISN’T.
SOME OF IT ISN’T. WE HAVE TO WAIT AND SEE.
WE HAVE TO WAIT AND SEE. RIGHT NOW I SEE SEVERAL
RIGHT NOW I SEE SEVERAL ORGANIZATIONS ATTEMPTING TO
ORGANIZATIONS ATTEMPTING TO ORGANIZE THE FIELD.
ORGANIZE THE FIELD. BUT IT’S GOING TO BE A BIG
BUT IT’S GOING TO BE A BIG QUESTION HOW YOU NARROW DOWN
QUESTION HOW YOU NARROW DOWN FROM MORE THAN 70 TO ONE, TWO,
FROM MORE THAN 70 TO ONE, TWO, THREE THAT ARE GOING TO BE
THREE THAT ARE GOING TO BE PRODUCED.
PRODUCED. I MEAN I DON’T KNOW IN THE END
I MEAN I DON’T KNOW IN THE END HOW MANY WILL WORK.
HOW MANY WILL WORK. I DON’T KNOW IF ANY WILL WORK.
I DON’T KNOW IF ANY WILL WORK. I’M HOPEFUL THAT WE’LL HAVE A
I’M HOPEFUL THAT WE’LL HAVE A VACCINE.
VACCINE. IT DOESN’T LOOK LIKE THAT TOUGH
IT DOESN’T LOOK LIKE THAT TOUGH OF A SCIENTIFIC NUT TO CRACK.
OF A SCIENTIFIC NUT TO CRACK. BUT THERE’S A LOT OF
BUT THERE’S A LOT OF UNCERTAINTY, AND THAT’S HARD FOR
UNCERTAINTY, AND THAT’S HARD FOR PEOPLE TO ACCEPT, BUT THAT’S
PEOPLE TO ACCEPT, BUT THAT’S REALITY.
REALITY. >> AND IF WE GET TO THE POINT
>> AND IF WE GET TO THE POINT WHERE THAT NUT HAS BEEN CRACKED,
WHERE THAT NUT HAS BEEN CRACKED, AS YOU PUT IT, AND THERE IS A
AS YOU PUT IT, AND THERE IS A VACCINE AND IT’S A VACCINE THAT
VACCINE AND IT’S A VACCINE THAT SEEMS VERY RELIABLE AND ACTUALLY
SEEMS VERY RELIABLE AND ACTUALLY GETS TO THE POINT OF BEING
GETS TO THE POINT OF BEING PROVEN TO BE RELIABLE, HOW DO
PROVEN TO BE RELIABLE, HOW DO YOU SCALE UP THE MANUFACTURE OF
YOU SCALE UP THE MANUFACTURE OF THAT TO DELIVER IT NOT JUST TO
THAT TO DELIVER IT NOT JUST TO THE 330 MILLION AMERICANS WHO
THE 330 MILLION AMERICANS WHO WANT IT RIGHT AWAY BUT THE WHOLE
WANT IT RIGHT AWAY BUT THE WHOLE WORLD WANTS IT RIGHT AWAY?
WORLD WANTS IT RIGHT AWAY? >> YEAH, THAT’S A HUGE
>> YEAH, THAT’S A HUGE CHALLENGE.
CHALLENGE. AND PEOPLE ARE FORTUNATELY
AND PEOPLE ARE FORTUNATELY PUTTING SOME THOUGHT INTO THAT
PUTTING SOME THOUGHT INTO THAT NOW.
NOW. BILL GATES HAS TALKED ABOUT EVEN
BILL GATES HAS TALKED ABOUT EVEN FINANCING BUILDING PLANTS FOR
FINANCING BUILDING PLANTS FOR VACCINES THAT NEVER GET MADE SO
VACCINES THAT NEVER GET MADE SO THAT THAT PROBLEM DOESN’T OCCUR.
THAT THAT PROBLEM DOESN’T OCCUR. QUESTIONS OF EQUITY AND ACCESS
QUESTIONS OF EQUITY AND ACCESS ARE GOING TO BECOME REAL IF
ARE GOING TO BECOME REAL IF THERE IS A WORKING VACCINE.
THERE IS A WORKING VACCINE. THERE ARE BIG PHARMACEUTICAL
THERE ARE BIG PHARMACEUTICAL COMPANIES IN THE GAME.
COMPANIES IN THE GAME. THERE ALSO ARE SOME
THERE ALSO ARE SOME OLD-FASHIONED TECHNOLOGIES THAT
OLD-FASHIONED TECHNOLOGIES THAT ARE HERE THAT MOST EVERYONE
ARE HERE THAT MOST EVERYONE COULD DO.
COULD DO. SO WE HAVE TO JUST WAIT AND SEE
SO WE HAVE TO JUST WAIT AND SEE WHAT PROVES EFFECTIVE.
WHAT PROVES EFFECTIVE. I THINK IT’S IMPORTANT TO TALK
I THINK IT’S IMPORTANT TO TALK ABOUT IT NOW BECAUSE EQUITY AND
ABOUT IT NOW BECAUSE EQUITY AND ACCESS ARE HARD TO TALK ABOUT
ACCESS ARE HARD TO TALK ABOUT AFTER THE FACT.
AFTER THE FACT. >> WELL, I MEAN EQUITY, IF WE
>> WELL, I MEAN EQUITY, IF WE JUST LOOKED AT IT IN NATIONAL
JUST LOOKED AT IT IN NATIONAL TERMS AND DIDN’T THINK BEYOND
TERMS AND DIDN’T THINK BEYOND OUR BORDERS, FOR EXAMPLE, HOW
OUR BORDERS, FOR EXAMPLE, HOW AFRICAN COUNTRIES CAN POSSIBLY
AFRICAN COUNTRIES CAN POSSIBLY COMPETE WITH US TO GET THE
COMPETE WITH US TO GET THE VACCINE, JUST WITHIN THE UNITED
VACCINE, JUST WITHIN THE UNITED STATES, HOW LONG DO YOU THINK IT
STATES, HOW LONG DO YOU THINK IT WOULD TAKE TO GET FROM THE
WOULD TAKE TO GET FROM THE PRIVILEGED WHERE IT WOULD SURELY
PRIVILEGED WHERE IT WOULD SURELY BEGIN IN TERMS OF DISTRIBUTION
BEGIN IN TERMS OF DISTRIBUTION ALL THE WAY THROUGH TO THE
ALL THE WAY THROUGH TO THE POVERTY POPULATION OF AMERICA?
POVERTY POPULATION OF AMERICA? >> I’VE NEVER SEEN ANYTHING HIT
>> I’VE NEVER SEEN ANYTHING HIT THE ENTIRE WORLD THE WAY THIS
THE ENTIRE WORLD THE WAY THIS VIRUS HAS HIT IT, AND MAYBE
VIRUS HAS HIT IT, AND MAYBE CLIMATE CHANGE HAS, BUT SOME
CLIMATE CHANGE HAS, BUT SOME PEOPLE DON’T EVEN BELIEVE IN
PEOPLE DON’T EVEN BELIEVE IN THAT.
THAT. EVERYONE BELIEVES IN THIS VIRUS.
EVERYONE BELIEVES IN THIS VIRUS. I DON’T THINK WE’RE GOING TO BE
I DON’T THINK WE’RE GOING TO BE ABLE TO SILO OURSELVES LIKE THAT
ABLE TO SILO OURSELVES LIKE THAT AS THE UNITED STATES.
AS THE UNITED STATES. SO LET’S JUST SAY WHAT’S THE
SO LET’S JUST SAY WHAT’S THE TIMELINE FOR ANY COUNTRY?
TIMELINE FOR ANY COUNTRY? AND IT COULD WELL BE CHINA, TO
AND IT COULD WELL BE CHINA, TO MAKE A VACCINE AND PROVE THAT IT
MAKE A VACCINE AND PROVE THAT IT WORKS.
WORKS. THE ESTIMATES ARE AT LEAST A
THE ESTIMATES ARE AT LEAST A YEAR IF EVERYTHING GOES WELL.
YEAR IF EVERYTHING GOES WELL. I’VE WATCHED A LOT OF VACCINE
I’VE WATCHED A LOT OF VACCINE DEVELOPMENT.
DEVELOPMENT. THINGS DON’T GO WELL MOST OF THE
THINGS DON’T GO WELL MOST OF THE TIME.
TIME. THERE ARE SMALL PROBLEMS THAT
THERE ARE SMALL PROBLEMS THAT CROP UP EVEN WITH SOMETHING
CROP UP EVEN WITH SOMETHING THAT’S A GOOD VACCINE.
THAT’S A GOOD VACCINE. SO SAY IT’S A YEAR, SAY IT’S 18
SO SAY IT’S A YEAR, SAY IT’S 18 MONTHS, AND THAT’S OPTIMISTIC.
MONTHS, AND THAT’S OPTIMISTIC. THERE ARE ATTEMPTS TO SPEED
THERE ARE ATTEMPTS TO SPEED THINGS UP MORE QUICKLY, TO MAKE
THINGS UP MORE QUICKLY, TO MAKE SOME SHORTCUTS.
SOME SHORTCUTS. THEY’RE INVENTIVE, AND THEY
THEY’RE INVENTIVE, AND THEY COULD WORK.
COULD WORK. BUT WE’RE TALKING BIG GAMBLES.
BUT WE’RE TALKING BIG GAMBLES. >> AND LET’S SAY THE VACCINE IS
>> AND LET’S SAY THE VACCINE IS DEVELOPED.
DEVELOPED. DOES IT TAKE ANOTHER YEAR AFTER
DOES IT TAKE ANOTHER YEAR AFTER IT’S DEVELOPED FOR IT TO BE
IT’S DEVELOPED FOR IT TO BE DISTRIBUTED TO ALL AMERICANS OR
DISTRIBUTED TO ALL AMERICANS OR MORE THAN A YEAR?
MORE THAN A YEAR? >> NOT NECESSARILY.
>> NOT NECESSARILY. I MEAN WE COULD RAMP UP
I MEAN WE COULD RAMP UP PRODUCTION DEPENDING ON THE
PRODUCTION DEPENDING ON THE TECHNOLOGY THAT’S BEING USED.
TECHNOLOGY THAT’S BEING USED. WE COULD RAMP UP PRODUCTION TO
WE COULD RAMP UP PRODUCTION TO HUNDREDS OF MILLIONS, IF NOT
HUNDREDS OF MILLIONS, IF NOT BILLIONS OF DOSES IF WE PREPARE
BILLIONS OF DOSES IF WE PREPARE PROPERLY.
PROPERLY. AND I THINK THE DISCUSSIONS ARE
AND I THINK THE DISCUSSIONS ARE HAPPENING NOW.
HAPPENING NOW. I’M HEARTENED TO SEE THAT.
I’M HEARTENED TO SEE THAT. BUT, YOU KNOW, I’M A SKEPTIC.
BUT, YOU KNOW, I’M A SKEPTIC. I THINK WE HAVE TO REMAIN
I THINK WE HAVE TO REMAIN SKEPTICAL ABOUT THIS UNTIL WE
SKEPTICAL ABOUT THIS UNTIL WE REALLY SEE THE PLANTS ARE BUILT
REALLY SEE THE PLANTS ARE BUILT AND ARE RUNNING AND PEOPLE ARE
AND ARE RUNNING AND PEOPLE ARE DOING THESE THINGS.
DOING THESE THINGS. LOTS OF LITTLE THINGS CAN TRIP
LOTS OF LITTLE THINGS CAN TRIP UP PRODUCTION OF A BIOLOGICAL
UP PRODUCTION OF A BIOLOGICAL PRODUCT LIKE A VACCINE.
PRODUCT LIKE A VACCINE. THIS ISN’T MAKING A DRUG WITH
THIS ISN’T MAKING A DRUG WITH CHEMICALS, YOU KNOW.
CHEMICALS, YOU KNOW. IT’S TAKING THE VIRUS,

Share Video:

Embed Video: